Brachytherapy for Pediatric Patients at Gustave Roussy Cancer Campus: A Model of International Cooperation for Highly Specialized Treatments

Cyrus Chargari, Christine Haie-Meder, Sophie Espenel, Max-Adrien Garcia, Myriam Ben-Arush, Stéphanie Bolle, Anna Borjesson, Maja Cesen, Rita Costa Lago, Anne-Sophie Defachelles, Barbara De Moerloose, Christine Devalck, Pernille Edslev, Nuno Jorge Farinha, Nadine Francotte, Heidi Glosli, Sebastien Gouy, Gabriela Guillen Burrieza, Sylvie Helfre, Sabine IrtanAntonis Kattamis, Ana Lacerda, Antonin Levy, Lisa Lyngsie Hjalgrim, Ludovic Mansuy, Eric Mascard, Salma Moalla, Daniel Orbach, Cormac Owens, Pascale Philippe-Chomette, Barry Pizer, Claire Pluchart, Marleen Renard, Anne Gro Wesenberg Rognlien, Angélique Rome, Sabine Sarnacki, Akmal Safwat, Amalia Schiavetti, Jill Serre, Cécile Verite, Nicolas Von Der Weid, Mariusz Wysocki, Dominique Valteay-Couanet, Eric Deutsch, Véronique Minard-Colin, Hélène Martelli, Florent Guérin

12 Citationer (Scopus)

Abstract

PURPOSE: Childhood cancer is rare, and treatment is frequently associated with long-term morbidity. Disparities in survival and long-term side effects encourage the establishment of networks to increase access to complex organ-conservative strategies, such as brachytherapy. We report our experience of an international cooperation model in childhood cancers.

METHODS AND MATERIALS: We examined the outcome of all children referred to our center from national or international networks to be treated according to a multimodal organ-conservative approach, including brachytherapy.

RESULTS: We identified 305 patients whose median age at diagnosis was 2.2 years (range, 1.4 months to 17.2 years). Among these patients, 99 (32.4%) were treated between 2015 and 2020; 172 (56.4%) were referred from national centers; and 133 (43.6%) were international patients from 31 countries (mainly Europe). Also, 263 patients were referred for primary treatment and 42 patients were referred for salvage treatment. Genitourinary tumors were the most frequent sites, with 56.4% bladder/prostate rhabdomyosarcoma and 28.5% gynecologic tumors. In addition to brachytherapy, local treatment consisted of partial tumor resection in 207 patients (67.9%), and 39 patients (13%) had additional external radiation therapy. Median follow-up was 58 months (range, 1 month to 48 years), 93 months for national patients, and 37 months for international patients (P < .0001). Five-year local control, disease-free survival, and overall survival rates were 90.8% (95% confidence interval [CI], 87.3%-94.4%), 84.4% (95% CI, 80.1%-89.0%), and 93.3% (95% CI, 90.1%-96.5%), respectively. Patients referred for salvage treatment had poorer disease-free survival (P < .01). Implementation of image guided pulse-dose-rate brachytherapy was associated with better local control among patients with rhabdomyosarcoma referred for primary treatment (hazard ratio, 9.72; 95% CI, 1.24-71.0). At last follow-up, 16.7% patients had long-term severe treatment-related complications, and 2 patients (0.7%) had developed second malignancy.

CONCLUSIONS: This retrospective series shows the feasibility of a multinational referral network for brachytherapy allowing high patient numbers in rare pediatric cancers. High local control probability and acceptable late severe complication probability could be achieved despite very challenging situations. This cooperation model could serve as a basis for generating international reference networks for high-tech radiation such as brachytherapy to increase treatment care opportunities and cure probability.

OriginalsprogEngelsk
TidsskriftInternational journal of radiation oncology, biology, physics
Vol/bind113
Udgave nummer3
Sider (fra-til)602-613
Antal sider12
ISSN0360-3016
DOI
StatusUdgivet - 1 jul. 2022

Fingeraftryk

Dyk ned i forskningsemnerne om 'Brachytherapy for Pediatric Patients at Gustave Roussy Cancer Campus: A Model of International Cooperation for Highly Specialized Treatments'. Sammen danner de et unikt fingeraftryk.

Citationsformater